Fabienne Le Frere
Nantes, 44000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.
Journal: Brain : a journal of neurology
Published: October 13, 2025
Durable B-Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis.
Durable B-Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis.
Journal: Annals of clinical and translational neurology
Published: March 27, 2025
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 17, 2022
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8+ Regulatory T Cells.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 19, 2022
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis.
Journal: Journal of neurology
Published: April 22, 2020
An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis.
Journal: Journal of autoimmunity
Published: September 10, 2017
Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 17, 2015
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: June 14, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026